personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the January issue. Our upfront topics range from a cross-country cancer cost comparison, to details of the French cancer trial tragedy. Our feature speculates on the future of the Biopharmaceutical Industry – discussing the role of Immuno-oncology, gene editing and other emerging therapeutic techniques. In best practice, Lisa Allen discusses the approaching deadline for the European Union’s REACH regulation, in NextGen, Miguel Forte discusses the role of vendors and manufacturing organizations to cell therapies, and we Sit Down With Diane Paskiet of West Pharmaceutical Services.